Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) Antibody

What is the specificity of the Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) antibody?

The Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) antibody specifically detects endogenous levels of Casein Kinase Iγ1/2/3 proteins only when phosphorylated at tyrosine 263. This antibody was developed using a synthesized phospho-peptide derived from human Casein Kinase Iγ1/2/3 around the phosphorylation site of Y263 . The specificity has been validated through blocking experiments with phospho-peptides, where antibody binding is prevented when pre-incubated with the specific phospho-peptide but not with non-phosphorylated peptides .

What applications have been validated for this antibody?

The antibody has been primarily validated for:

While these are the established applications, researchers have also explored its potential utility in immunofluorescence and western blotting for specific experimental setups, though these may require additional optimization .

What storage conditions are optimal for maintaining antibody activity?

For long-term storage, the antibody should be kept at -20°C or -80°C. Upon receipt, it is recommended to aliquot the antibody to avoid repeated freeze-thaw cycles. The product is typically supplied as a liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide, which helps maintain stability . Storage in these conditions typically ensures antibody stability for at least one year after shipment.

How should researchers optimize immunohistochemistry protocols using this antibody?

When optimizing IHC protocols with the Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) antibody, consider the following approach:

• Antigen retrieval optimization: For paraffin-embedded tissues, heat-induced epitope retrieval using either citrate buffer (pH 6.0) or TE buffer (pH 9.0) should be tested to determine optimal conditions .

• Titration strategy: Begin with the middle of the recommended range (1:200) and adjust based on signal-to-noise ratio.

• Validation controls:

  • Positive control: Human brain tissue has shown consistent positive staining .

  • Negative control: Perform peptide competition assays using the phospho-peptide to confirm specificity.

  • Tissue-specific positive controls should be selected based on known expression patterns of CSNK1G isoforms.

• Signal detection: Both DAB and fluorescent secondary antibodies have been successfully used, with the choice depending on the specific research question.

The immunohistochemistry validation data from search results shows clear nuclear and cytoplasmic staining patterns that are eliminated when blocked with the phospho-peptide, demonstrating antibody specificity .

What are the best practices for validating phospho-specific antibody results?

To ensure the validity of results obtained with the Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) antibody:

• Phosphatase treatment controls: Treat one sample set with lambda phosphatase prior to antibody incubation to confirm phospho-specificity.

• Phospho-peptide competition: Pre-incubate the antibody with increasing concentrations of the phospho-peptide immunogen to demonstrate specific blocking .

• Non-phospho peptide controls: Include non-phosphorylated peptide controls to verify that only the phosphorylated form blocks antibody binding.

• Kinase activation/inhibition: When possible, include samples where relevant kinase pathways are experimentally activated or inhibited to modulate Y263 phosphorylation status.

• Cross-validation: Compare results with alternative methods of detecting phosphorylation, such as mass spectrometry, when feasible.

What is the functional significance of Y263 phosphorylation in CSNK1G proteins?

The tyrosine 263 (Y263) phosphorylation site in CSNK1G isoforms appears to serve as a regulatory mechanism for kinase activity and protein-protein interactions. While the specific kinases responsible for Y263 phosphorylation have not been fully characterized, several functions may be regulated by this modification:

• Subcellular localization control: Phosphorylation at Y263 may influence the compartmentalization of CSNK1G proteins, as research indicates that C-terminal modifications affect localization. In CSNK1G3, C-terminal truncation mutations dramatically altered its localization from punctate endosomal structures to diffuse cytosolic and nuclear distribution .

• Kinase activity regulation: Y263 phosphorylation likely modulates the kinase activity toward substrates, potentially creating binding sites for regulatory proteins.

• Protein-protein interaction modulation: Phosphorylation status may determine binding to interaction partners, similar to how CSNK1G2 phosphorylation at S211/T215 regulates its interaction with RIPK3 in necroptosis pathways .

These hypotheses are supported by studies showing that CSNK1G proteins are involved in diverse cellular processes including Wnt signaling, DNA repair, membrane transport, and oxidative stress responses .

How do the three CSNK1G isoforms (CSNK1G1, CSNK1G2, CSNK1G3) differ in their biological functions?

The three CSNK1G isoforms share structural similarities but exhibit distinct functional roles:

Despite these differences, the isoforms show functional redundancy in some contexts, such as in regulating Wnt signaling pathways and oxidative stress responses. In C. elegans, the CSNK1G ortholog (CSNK-1) interacts with NADPH dual oxidase genes to regulate ROS levels, a function that appears to be conserved in mammalian CSNK1G proteins .

What experimental models are most suitable for studying CSNK1G phosphorylation?

Based on current research, the following experimental models are recommended for studying CSNK1G phosphorylation:

• Cell lines:

  • HEK293T cells: Successfully used for overexpression and co-immunoprecipitation studies of CSNK1G proteins

  • HeLa cells: Demonstrated endogenous expression of CSNK1G1 and suitable for CRISPR/Cas9 gene editing

  • Jurkat cells: Show detectable endogenous CSNK1G1 expression for immunoprecipitation studies

• Animal models:

  • CSNK1G2 knockout mice: Show enhanced necroptosis response and premature testis aging

  • C. elegans: csnk-1 mutants demonstrate altered oxidative stress responses, allowing evolutionary conservation studies

• Primary tissues:

  • Human and mouse brain tissue: Demonstrates detectable phospho-CSNK1G expression in IHC applications

  • Testis tissue: Co-expression of CSNK1G2 and RIPK3 observed in both human and mouse models

How can researchers distinguish between phosphorylation of the three CSNK1G isoforms using this antibody?

Since the Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) antibody recognizes all three isoforms when phosphorylated at Y263, additional strategies are required to discriminate between them:

• Combined immunoprecipitation approach:

  • First immunoprecipitate with isoform-specific antibodies

  • Then probe with the phospho-Y263 antibody in western blots

• Mass spectrometry analysis:

  • Immunoprecipitate using the phospho-Y263 antibody

  • Perform mass spectrometry to identify unique peptides specific to each isoform

• Genetic manipulation:

  • Use CRISPR/Cas9 to generate single, double, or triple knockout cell lines

  • Sequentially reintroduce individual isoforms to determine contribution to total Y263 phosphorylation

• Isoform-specific siRNA knockdown:

  • Selectively deplete each isoform and quantify changes in phospho-Y263 signal

This combined approach allows researchers to determine the relative contribution of each isoform to the total phospho-Y263 signal in their specific experimental context.

What is the relationship between CSNK1G phosphorylation and oxidative stress pathways?

Recent research has revealed an emerging role for CSNK1G proteins in regulating oxidative stress responses:

• C. elegans studies: CSNK-1 (the C. elegans ortholog of mammalian CSNK1G) genetically interacts with the bli-3/tsp-15/doxa-1 NADPH dual oxidase genes to regulate reactive oxygen species (ROS) levels. Loss of CSNK-1 function results in altered oxidative stress responses and survival .

• Biochemical interactions: Specific biochemical interactions have been detected between CSNK-1 and DOXA-1 in C. elegans, with similar interactions potentially occurring between their human orthologs CSNK1G2 and DUOXA2 .

• ROS regulation: CSNK-1 is required for maintaining normal ROS levels in C. elegans, and human CSNK1G2 can promote ROS levels in cultured cells. This effect can be suppressed using casein kinase 1 inhibitors such as D4476 .

• Genetic interactions: CSNK-1 also interacts with SKN-1 (ortholog of mammalian Nrf2), a key transcription factor in oxidative stress response pathways .

These findings suggest that monitoring CSNK1G phosphorylation status, including at Y263, may provide insights into cellular responses to oxidative stress conditions. Researchers studying redox biology should consider incorporating phospho-CSNK1G analysis into their experimental designs.

How might the phosphorylation at Y263 crosstalk with other post-translational modifications on CSNK1G proteins?

The potential crosstalk between Y263 phosphorylation and other post-translational modifications on CSNK1G proteins represents an important frontier for research:

• Auto-phosphorylation sites: In CSNK1G2, auto-phosphorylation at S211/T215 is critical for interaction with RIPK3 . How Y263 phosphorylation influences or is influenced by these auto-phosphorylation events remains to be determined.

• C-terminal modifications: The C-terminal region of CSNK1G3 is critical for subcellular localization to endosomal compartments . Y263 phosphorylation could potentially modulate interactions with membrane components or trafficking proteins.

• Palmitoylation sites: C-terminal palmitoylation of CSNK-1 (C. elegans ortholog) is important for its function in oxidative stress responses . Investigating whether Y263 phosphorylation affects palmitoylation or vice versa could reveal regulatory mechanisms.

• Ubiquitination and degradation: Research should explore if Y263 phosphorylation serves as a recognition signal for ubiquitin ligases or stabilizes the protein against degradation.

Researchers interested in this area should consider employing mass spectrometry-based approaches to comprehensively map all modifications on CSNK1G proteins under various cellular conditions and stimuli.

What are common technical challenges when using phospho-specific antibodies like Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263)?

When working with the Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) antibody, researchers should be aware of these common challenges and solutions:

• Phosphatase activity during sample preparation:

  • Challenge: Rapid dephosphorylation during cell lysis can reduce signal

  • Solution: Include phosphatase inhibitor cocktails in all buffers; keep samples cold throughout processing

• Antibody specificity concerns:

  • Challenge: Cross-reactivity with similar phosphorylation motifs

  • Solution: Always include peptide competition controls; consider using tissues/cells from knockout models as negative controls

• Variability in phosphorylation levels:

  • Challenge: Phosphorylation is dynamic and can change rapidly with cell culture conditions

  • Solution: Standardize harvesting protocols; consider time-course experiments to capture phosphorylation dynamics

• Fixation-induced epitope masking in IHC:

  • Challenge: Phospho-epitopes can be particularly sensitive to overfixation

  • Solution: Optimize fixation time; test multiple antigen retrieval methods (citrate pH 6.0 vs. EDTA pH 9.0)

• Background in immunohistochemistry:

  • Challenge: High background can obscure specific signals

  • Solution: Optimize blocking conditions; include endogenous peroxidase quenching step; titrate primary antibody carefully

How can researchers verify the reproducibility of findings using this phospho-specific antibody?

To ensure reproducible results with the Phospho-CSNK1G1/CSNK1G2/CSNK1G3 (Y263) antibody:

• Lot-to-lot comparison:

  • Test new antibody lots against previous lots using identical samples

  • Document lot numbers used for all experiments

• Validation across multiple techniques:

  • Confirm findings using complementary approaches (e.g., if found in IHC, verify with western blot when possible)

  • Consider alternative methods for detecting phosphorylation (e.g., mass spectrometry)

• Biological replicates:

  • Use samples from multiple independent sources/donors

  • For cell lines, maintain separate cultures and perform experiments across multiple passages

• Processing controls:

  • Process all comparative samples simultaneously with identical protocols

  • Include internal controls for phosphorylation status (e.g., samples treated with phosphatases)

• Quantitation methods:

  • Use digital image analysis rather than subjective scoring when possible

  • Blind observers to sample identity during quantification

  • Apply consistent thresholds across all analyzed samples

These practices will help ensure that findings regarding CSNK1G phosphorylation status are robust and reproducible across different research settings.